GLP-1 and Opioid Use Disorder Research Study
Are you an adult who’s recently started buprenorphine treatment (like Suboxone®) for opioid use disorder? We’re running a national, multi-site research study testing whether tirzepatide (Mounjaro®/Zepbound®) can help people stay in buprenorphine treatment longer. If you’re interested in learning more or seeing if you’re eligible, please reach out to one of the locations below:
Tarzana, CA: Tarzana Treatment Centers: 818-996-1051 x1336, CTNResearch@Tarzanatc.org
Jacksonville, FL: Gateway Community Services: 904-651-4396, TAB@GWJax.com
Tampa, FL: Ibis Healthcare, Inc.: 813-384-4050, researchteam@ibishc.org
Chicago, IL: Ruth M. Rothstein CORE Center: 312-572-4576, joy.jibunoh@cookcountyhealth.org
Cape Girardeau, MO: The Gibson Center for Behavioral Change: 573-571-1113, TAB@gibsonrecovery.org
Greenville, SC: Prisma Health: 864-960-5087, Noura.Abualeinan@PrismaHealth.org
Nashville, TN: VUMC: 615-587-9669, vumc.ctn152tab@vumc.org
Salt Lake City, UT: University of Utah: 385-977-2445, tab@utah.edu
Huntington, WV: Marshall Health: 740-442-2795, taylor975@marshall.edu
Morgantown, WV: Healthy Minds/Chestnut Ridge: 304-288-6324, wvutabstudy@hsc.wvu.edu